Results
122
122 companies
High Tide
Market Cap: CA$432.9m
Engages in the cannabis retail business in Canada.
HITI
CA$5.24
7D
3.8%
1Y
89.2%
Hanall Biopharma
Market Cap: ₩1.7t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩32,850.00
7D
-0.8%
1Y
-15.2%
AFT Pharmaceuticals
Market Cap: NZ$292.6m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.79
7D
7.7%
1Y
-12.8%
Kamada
Market Cap: ₪1.3b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪23.02
7D
0.3%
1Y
15.8%
Valneva
Market Cap: €785.5m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
VLA
€4.95
7D
15.2%
1Y
90.5%
Aurora Cannabis
Market Cap: CA$488.9m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$8.31
7D
19.7%
1Y
14.1%
Dynavax Technologies
Market Cap: US$1.1b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
DVAX
US$9.66
7D
-0.3%
1Y
-13.3%
Kiniksa Pharmaceuticals International
Market Cap: US$2.7b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$38.77
7D
7.5%
1Y
55.1%
Takara Bio
Market Cap: JP¥112.2b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥932.00
7D
-1.5%
1Y
-11.4%
Kidswell Bio
Market Cap: JP¥12.7b
Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.
4584
JP¥267.00
7D
-2.6%
1Y
115.3%
Aarti Drugs
Market Cap: ₹44.3b
Through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.
524348
₹485.90
7D
-5.4%
1Y
-6.8%
Chugai Pharmaceutical
Market Cap: JP¥10.6t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,448.00
7D
-3.5%
1Y
-8.8%
Jubilant Pharmova
Market Cap: ₹170.8b
Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.
530019
₹1,078.55
7D
-0.5%
1Y
-7.6%
Seegene
Market Cap: ₩1.1t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩24,750.00
7D
-5.7%
1Y
0%
JBM (Healthcare)
Market Cap: HK$2.4b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.99
7D
-0.3%
1Y
205.1%
Hyphens Pharma International
Market Cap: S$109.6m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.35
7D
-5.3%
1Y
22.4%
Oxford Biomedica
Market Cap: UK£670.6m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£5.58
7D
-5.3%
1Y
46.3%
Neurocrine Biosciences
Market Cap: US$14.1b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$140.27
7D
-4.3%
1Y
21.7%
Green Thumb Industries
Market Cap: CA$2.3b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$11.72
7D
11.5%
1Y
-17.1%
Medical Developments International
Market Cap: AU$80.6m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.71
7D
8.3%
1Y
62.5%
Granules India
Market Cap: ₹125.3b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.
532482
₹516.20
7D
-1.4%
1Y
-10.9%
Essex Bio-Technology
Market Cap: HK$3.0b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.26
7D
0%
1Y
94.8%
IBN SINA Pharmaceutical Industry
Market Cap: ৳9.6b
Produces and sells pharmaceutical drugs in Bangladesh and internationally.
IBNSINA
৳307.30
7D
-2.1%
1Y
-15.8%
Emcure Pharmaceuticals
Market Cap: ₹242.6b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,279.90
7D
-3.4%
1Y
-14.4%
IOL Chemicals and Pharmaceuticals
Market Cap: ₹30.1b
Manufactures and sells pharmaceutical and chemical products in India and internationally.
524164
₹102.47
7D
-10.7%
1Y
7.9%
Eurofins Scientific
Market Cap: €10.8b
Provides various analytical testing and laboratory services worldwide.
ERF
€61.78
7D
-1.1%
1Y
8.8%
Vitrolife
Market Cap: SEK 17.6b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 129.70
7D
0.4%
1Y
-48.4%
hVIVO
Market Cap: UK£54.4m
Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
HVO
UK£0.078
7D
-6.0%
1Y
-72.1%
Aytu BioPharma
Market Cap: US$17.2m
A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.
AYTU
US$1.71
7D
-31.3%
1Y
-27.2%
Vericel
Market Cap: US$1.5b
A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.
VCEL
US$31.79
7D
-0.06%
1Y
-24.8%
Neuphoria Therapeutics
Market Cap: US$23.1m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$11.86
7D
20.3%
1Y
n/a
Repligen
Market Cap: US$7.1b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$124.09
7D
-1.5%
1Y
-16.6%
Harmony Biosciences Holdings
Market Cap: US$1.6b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$27.64
7D
-14.7%
1Y
-30.9%
Mayne Pharma Group
Market Cap: AU$418.4m
A specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.
MYX
AU$5.15
7D
1.2%
1Y
8.0%
PeptiDream
Market Cap: JP¥203.2b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,572.50
7D
-5.5%
1Y
-42.4%
Aroa Biosurgery
Market Cap: AU$224.3m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.65
7D
-4.4%
1Y
18.2%